PHARMA MAR, S.A. 12/12/2023 14:33 PHARMA MAR, S.A. On business and financial situation The Company announces that its partner Luye Pharma Group Ltd has received approval for commercialization for Zepzelca® (lurbinectedina) in Hong Kong. Register number: 25763